Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001858491 | SCV002310672 | uncertain significance | not provided | 2021-07-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 690609). This variant has not been reported in the literature in individuals affected with HOXB13-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with serine at codon 63 of the HOXB13 protein (p.Cys63Ser). The cysteine residue is moderately conserved and there is a moderate physicochemical difference between cysteine and serine. |
Laboratory of Virology, |
RCV000855912 | SCV000993903 | uncertain significance | Prostate cancer, hereditary, 1 | no assertion criteria provided | clinical testing |